Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kei Tazume"'
Autor:
Daisuke Ogiya, Norie Murayama, Yusuke Kamiya, Rie Saito, Sawako Shiraiwa, Rikio Suzuki, Shinichiro Machida, Kei Tazume, Kiyoshi Ando, Hiroshi Yamazaki
Publikováno v:
Annals of Hematology. 101:2013-2019
Lenalidomide is a synthetic analog of thalidomide formed by the removal of one keto group (plus the addition of an amino group); it has anti-tumor activities beneficial for the treatment of hematologic malignancies. However, lenalidomide distribution
Clinicopathological Analysis of 320 Cases of Diffuse Large B-cell Lymphoma Using the Hans Classifier
Autor:
Akifumi Ichiki, Ken Ohmachi, Yoshiaki Ogawa, Yara Yukie Kikuti, Kei Tazume, Naoya Nakamura, Shigeki Watanabe, Joaquim Carreras, Tamotsu Sasao, Yukari Shirasugi, Yoshiaki Obayashi, Makoto Onizuka, Kiyoshi Ando, Fumiaki Yoshiba, Hiroshi Kawada, Masashi Miyaoka, Tadashi Jibiki
Publikováno v:
Journal of clinical and experimental hematopathology : JCEH. 57(2)
The estimation of clinical prognosis for diffuse large B-cell lymphoma (DLBCL) with a quick, cost-efficient method is necessary because of the clinical heterogeneity of this disease, which leads to death, relapsed or refractory disease in approximate
Autor:
Hidetsugu Kawai, Ai Sato, Joaquim Carreras, Akifumi Ichiki, Ryujiro Hara, Kiyoshi Ando, Daisuke Ohgiya, Ken Ohmachi, Hiroki Numata, Kei Tazume, Jun Amaki, Naoya Nakamura, Yara Yukie Kikuti, Hiroshi Kawada, Mitsuki Miyamoto, Yasuyuki Aoyama, Makiko Moriuchi, Yoshiaki Ogawa, Minoru Kojima
Publikováno v:
Cancer Science
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of malignant lymphoma. The incidence of Epstein–Barr virus (EBV)-positive DLBCL in Asian and Latin American countries ranges from 8 to 10%. The prognosis of patients with EBV-positive
Autor:
S Kato, Tomomitsu Hotta, Ayako Okamoto, Masao Hagihara, Aya Masui, Kei Tazume, Ying Yu, Balgansuren Gansuvd, Yoko Ueda, Ayako Higuchi
Publikováno v:
Cancer Immunology, Immunotherapy. 52:625-631
The first objective of this study was to investigate in vitro effects of α-galactosylceramide (αGalCer) on the proliferation of umbilical cord blood (UCB) natural killer T (NKT) cells and enhancement of their cytotoxicity. The second one is to exam
Autor:
Tomomitsu Hotta, Aya Masui, Osamu Hyodo, Shohei Matzusaki, Kei Tazume, Yoko Ueda, Shinji Takashimizu, Shunichi Kato, Masao Hagihara, Ayako Kanemura, Fumiaki Yoshiba, Takahide Tsuchiya
Publikováno v:
International Journal of Hematology. 78:62-68
Immune cell therapy with autologous Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes (CTLs) or lymphokine-activated killer (LAK) cells was performed in 2 adults with severe chronic active EBV infection (SCAEBV). The patient in case 1, who ha
Autor:
Aya Masui, Kei Tazume, Tomomitsu Hotta, Balgansuren Gansuvd, Takahide Tsuchiya, Yoko Ueda, Masao Hagihara, Hiroyasu Inoue, Shunichi Kato
Publikováno v:
Cancer Immunology, Immunotherapy. 51:1-8
Purpose: We aimed to determine the effects of human umbilical cord blood (UCB)-derived natural killer T (NKT) cells as immunological effectors against hematological malignancies, as well as auto- or allo-dendritic cells (DCs) or EB transformed cell l
Autor:
Masao Hagihara, Yoko Ueda, Takahide Tsuchiya, Shunichi Kato, Yasuhito Shimakura, Hiroyasu Inoue, Balgansuren Gansuvd, Kei Tazume, Tomomitsu Hotta, Batmunkh Munkhbat
Publikováno v:
International Journal of Hematology. 75:55-62
The ability of CD34+ leukemic cells to differentiate to dendritic cells (DCs) was investigated in 18 acute myeloid leukemia (AML) and 4 lymphoid leukemia (ALL) patients. The generation of DCs was determined by the expression of DC-associated CD1a or
Autor:
Hiroshi, Kawada, Masakazu, Sawanobori, Mitsuyo, Tsuma-Kaneko, Izumi, Wasada, Mitsuki, Miyamoto, Hiromichi, Murayama, Masako, Toyosaki, Makoto, Onizuka, Kosuke, Tsuboi, Kei, Tazume, Yukari, Shirasugi, Ken, Ohmachi, Yoshiaki, Ogawa, Hiroyuki, Kobayashi, Kiyoshi, Ando
Publikováno v:
The Tokai journal of experimental and clinical medicine. 39(3)
To determine the safety and the appropriate dose of intravenous l-ascorbic acid (AA) in conjunction with chemotherapy for patients with relapsed lymphoma.Patients with relapsed CD20-positive B-cell non-Hodgkin's lymphoma, who were going to receive th
Autor:
Ken, Ohmachi, Daisuke, Ogiya, Fujiko, Morita, Minoru, Kojima, Kosuke, Tsuboi, Kei, Tazume, Masamichi, Komatsu, Naoki, Hayama, Nobue, Kumaki, Yoshiaki, Ogawa, Kiyoshi, Ando
Publikováno v:
The Tokai journal of experimental and clinical medicine. 33(4)
Pulmonary alveolar proteinosis (PAP) is a rare respiratory disease the character of which is accumulation of protein consisting of surfactant in alveolar spaces. PAP sometimes complicates with hematological malignancies, especially myeloid leukemia.
Autor:
Ayako Higuchi, Motoharu Hojo, Yoko Ueda, Akiko Tanabe, Tomomitsu Hotta, Kaoru Hirabayashi, Ayako Okamoto, Balgansuren Gansuvd, Shunichi Kato, Kei Tazume, Masao Hagihara
Publikováno v:
Experimental hematology. 32(1)
Objective We generated cytomegalovirus (CMV)-specific cytotoxic T lymphocytes (CTL) in vitro using dendritic cells (DC) pulsed with crude CMV antigens (Ag). Materials and Methods Mononuclear cells from healthy CMV-seropositive or seronegative volunte